These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31146180)
1. Prognostic role of tumour-infiltrating T lymphocytes in stage IIA (T3N0) colon cancer: A broad methodological study in a fairly homogeneous population. Zengin M Ann Diagn Pathol; 2019 Aug; 41():69-78. PubMed ID: 31146180 [TBL] [Abstract][Full Text] [Related]
2. Local Inflammatory Response Can Predict Clinical Outcome in Patients with Curatively Resected Stage-IIB Colon Cancer: An Advanced Methodological Study. Zengin M Pathol Oncol Res; 2020 Jul; 26(3):1805-1816. PubMed ID: 31748877 [TBL] [Abstract][Full Text] [Related]
3. Tumour budding in preoperative biopsy specimens is a useful prognostic index for identifying high-risk patients in early-stage (pN0) colon cancer. Zengin M; Çifci A Turk J Med Sci; 2020 Apr; 50(2):375-385. PubMed ID: 32011836 [TBL] [Abstract][Full Text] [Related]
4. The Proportion of Tumour-Stroma in Metastatic Lymph Nodes is An Accurately Prognostic Indicator of Poor Survival for Advanced-Stage Colon Cancers. Zengin M; Benek S Pathol Oncol Res; 2020 Oct; 26(4):2755-2764. PubMed ID: 32696416 [TBL] [Abstract][Full Text] [Related]
5. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages. Kono-Sato T; Miyai K; Yamagishi Y; Miyamoto M; Takano M; Matsukuma S; Sato K; Tsuda H BMC Cancer; 2022 Apr; 22(1):361. PubMed ID: 35366828 [TBL] [Abstract][Full Text] [Related]
6. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034 [TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer. Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128 [TBL] [Abstract][Full Text] [Related]
9. Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy. Turksma AW; Coupé VM; Shamier MC; Lam KL; de Weger VA; Belien JA; van den Eertwegh AJ; Meijer GA; Meijer CJ; Hooijberg E Clin Cancer Res; 2016 Jan; 22(2):346-56. PubMed ID: 26420855 [TBL] [Abstract][Full Text] [Related]
10. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients. Zengin M Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570 [TBL] [Abstract][Full Text] [Related]
11. Tissue-Infiltrating Lymphocytes as a Predictive Factor for Recurrence in Patients with Curatively Resected Colon Cancer: A Propensity Score Matching Analysis. Chan LF; Sadahiro S; Suzuki T; Okada K; Miyakita H; Yamamoto S; Kajiwara H Oncology; 2020; 98(10):680-688. PubMed ID: 32526753 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma. Tomsová M; Melichar B; Sedláková I; Steiner I Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158 [TBL] [Abstract][Full Text] [Related]
13. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of tumor infiltration immune cells in pancreatic cancer]. Zhao KL; Liu J; Jiang WN; Hao JH Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):464-470. PubMed ID: 29886672 [No Abstract] [Full Text] [Related]
16. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646 [TBL] [Abstract][Full Text] [Related]
17. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study. Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640 [TBL] [Abstract][Full Text] [Related]
19. Intertumoral Heterogeneity of CD3 Yoon HH; Shi Q; Heying EN; Muranyi A; Bredno J; Ough F; Djalilvand A; Clements J; Bowermaster R; Liu WW; Barnes M; Alberts SR; Shanmugam K; Sinicrope FA Clin Cancer Res; 2019 Jan; 25(1):125-133. PubMed ID: 30301825 [TBL] [Abstract][Full Text] [Related]
20. Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma. Krpina K; Babarović E; Jonjić N Virchows Arch; 2015 Oct; 467(4):443-8. PubMed ID: 26215559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]